Intra-Cellular Therapies (BSP:I2TC34) Accumulated other comprehensive income (loss) : R$-2 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Intra-Cellular Therapies Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Intra-Cellular Therapies's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was R$-2 Mil.

Intra-Cellular Therapies's quarterly Accumulated other comprehensive income (loss) increased from Sep. 2023 (R$-7 Mil) to Dec. 2023 (R$1 Mil) but then declined from Dec. 2023 (R$1 Mil) to Mar. 2024 (R$-2 Mil).

Intra-Cellular Therapies's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 (R$-2 Mil) to Dec. 2022 (R$-22 Mil) but then increased from Dec. 2022 (R$-22 Mil) to Dec. 2023 (R$1 Mil).

Intra-Cellular Therapies Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Intra-Cellular Therapies's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intra-Cellular Therapies Accumulated other comprehensive income (loss) Chart

Intra-Cellular Therapies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated other comprehensive income (loss)

Get a 7-Day Free Trial

0.53

2.48

-2.06

-21.98

0.51

Intra-Cellular Therapies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial															-14.05	-11.01	-6.59	0.51	-2.14

Intra-Cellular Therapies Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Intra-Cellular Therapies Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Intra-Cellular Therapies's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Intra-Cellular Therapies (BSP:I2TC34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intra-Cellular Therapies Inc (BSP:I2TC34) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

ITCI:USA ITCI:Mexico 23I:Germany

Address

430 East 29th Street, New York, NY, USA, 10016

Website

https://www.intracellulartherapies.com

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

Intra-Cellular Therapies (BSP:I2TC34) Headlines

No Headlines